Tag: #HodgkinLymphoma
-

Fifteen-Year Follow-Up of Relapsed/Refractory Hodgkin Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation
Introduction Hodgkin lymphoma is a highly treatable malignancy; however, a subset of patients experience relapse or refractory disease requiring further intervention. A recent study published in the Journal of Stem Cell Therapy and Transplantation provides a comprehensive 15-year follow-up analysis of relapsed/refractory patients treated with autologous hematopoietic stem cell transplantation (AHSCT). The study sheds light…
